STAT

Opinion: Do business concerns keep doctors from treating opioid addiction?

A line from "The Godfather" — "It's not personal. It's strictly business." — captures why so few U.S. physicians have signed up to prescribe medication-assisted therapy for opioid use disorder.
Packets of buprenorphine

One morning last week as I arrived at our new addiction treatment center, the CAPA Clinic in St. Louis, one of the social work student interns I supervise couldn’t wait to tell me about the “excitement” they’d experienced in the few hours the clinic had been open for the day: a patient had been stabbed, another was screaming in the waiting room and had to be removed by the police, and detectives arrived to arrest one of the clinic’s clients.

That got me thinking about my participation in a new report from the National Academies of Science, Engineering, and Medicine. In it we noted that, despite the huge need for U.S. physicians to provide for opioid use disorder, only a small number of them have signed up to do it. The panel recommended that more join in.

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks